Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by…
Adamis shares slump as FDA declines to approve opioid overdose treatment
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, Zimhi, sending its shares plunging 56%. In a…
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel on Friday for use as an additional treatment…
Biohaven’s treatment for Lou Gehrig’s disease fails to win FDA nod
FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company’s IPO on the floor of the New York Stock Exchange (NYSE) in New…
Conatus Pharma to explore options as liver disease drug fails trial
(Reuters) – Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its liver disease drug failed in a mid-stage trial. The drug…
Enanta’s lung infection therapy succeeds in mid-stage trial
(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage…
Takeda scraps late-stage amyloidosis study
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo (Reuters) – Takeda Pharmaceutical Co Ltd said on Wednesday…
Exclusive: JPMorgan cuts ties with OxyContin maker Purdue Pharma – sources
(Reuters) – JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in the U.S. opioid crisis, forcing it to find a new…
Merck CEO Frazier to testify at Senate drug pricing hearing
NEW YORK/WASHINGTON (Reuters) – U.S. drugmaker Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans to testify at a Senate hearing later this month examining…